244 related articles for article (PubMed ID: 8989929)
21. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis.
Shimizu T; Oga A; Murakami T; Muto M
Dermatology; 1999; 199(2):113-8. PubMed ID: 10559575
[TBL] [Abstract][Full Text] [Related]
24. Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its association with human papillomavirus infection.
Wu YH; Hsiao PF; Chen CK
Am J Dermatopathol; 2015 Jun; 37(6):462-8. PubMed ID: 25747812
[TBL] [Abstract][Full Text] [Related]
25. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
26. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
Mihailovici MS; Teleman S; Ungureanu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
[TBL] [Abstract][Full Text] [Related]
27. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M
J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
[TBL] [Abstract][Full Text] [Related]
32. Bowenoid papulosis. Classification as a low-grade in situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidy studies.
Böcking A; Chatelain R; Salterberg A; Hagedorn M; Gross G
Anal Quant Cytol Histol; 1989 Dec; 11(6):419-25. PubMed ID: 2604822
[TBL] [Abstract][Full Text] [Related]
33. Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis.
Giuffrè G; Barresi V; Catalano A; Cappiello A; Stagno d'Alcontres F; Tuccari G
Eur J Histochem; 2008; 52(1):53-60. PubMed ID: 18502723
[TBL] [Abstract][Full Text] [Related]
34. Significance of mitotic cells or clumping cells in p53 immunopositivity of Bowen's disease.
Ura H; Nashiro K; Kikuchi K; Imakado S; Matsukawa A; Furue M
Dermatology; 1997; 194(1):87-8. PubMed ID: 9031804
[No Abstract] [Full Text] [Related]
35. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
36. Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?
Biesterfeld S; Pennings K; Grussendorf-Conen EI; Böcking A
Br J Dermatol; 1995 Oct; 133(4):557-60. PubMed ID: 7577583
[TBL] [Abstract][Full Text] [Related]
37. Eccrine porocarcinoma and Bowen's disease arising in a seborrhoeic keratosis.
Hoshina D; Akiyama M; Hata H; Aoyagi S; Sato-Matsumura KC; Shimizu H
Clin Exp Dermatol; 2007 Jan; 32(1):54-6. PubMed ID: 17004985
[TBL] [Abstract][Full Text] [Related]
38. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
[TBL] [Abstract][Full Text] [Related]
40. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
